Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

被引:66
|
作者
Tarkiainen, J
Vercouille, J
Emond, P
Sandell, J
Hiltunen, J
Frangin, Y
Guilloteau, D
Halldin, C [1 ]
机构
[1] Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Psychiat Sect, S-17176 Stockholm, Sweden
[2] Univ Tours, INSERM, U316, F-37200 Tours, France
[3] MAP Med Technol Oy, FIN-00251 Helsinki, Finland
关键词
C-11]MADAM; serotonin transporter; 5-HTT; carbon-11; PET;
D O I
10.1002/jlcr.523
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Imaging by scintigraphy the serotonin transporter (5-HTT) in the living human brain would be of great value in research on the pathophysiology and treatment of neuropsychiatric disorders such as depression. For that reason, and in order to obtain a selective radiotracer applicable to PET, we report here the carbon-11 labelling of a selective 5-HTT radioligand: N, N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine or MADAM in two different positions: [p-C-11-methyl]MADAM and [N-C-11-methyl]MADAM. The synthesis of Bu3Sn-ADAM and N-dimethyl-MADAM is described. [p-C-11-methyl]MADAM was obtained by a Stille coupling reaction between Bu3Sn-ADAM and [C-11]methyl iodide using palladium (0) as a catalyst without (Ia) or with cop-per chloride as a co-catalyst (Ib). [N-C-11-methyl]MADAM was obtained by an N-methylation reaction between N-demethyl-MADAM and [C-11]methyl iodide (II). The carbon-11 incorporation yield in [p-C-11-methyl]MADAM was 10-30% (Ia and Ib) and in [N-C-11-methyl]MADAM was 75-80% (II). The final product in each case was obtained in 30 min total synthesis time, including HPLC purification and with > 99% radiochemical purity. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:1013 / 1023
页数:11
相关论文
共 50 条
  • [21] Precursor synthesis and radiolabelling of [11C]ADAM:: A potential radioligand for the serotonin transporter exploration by PET
    Vercouillie, J
    Tarkiainen, S
    Halldin, C
    Emond, P
    Chalon, S
    Sandell, J
    Langer, O
    Guilloteau, D
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (02): : 113 - 120
  • [22] Carbon-11 epidepride:: A suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors
    Langer, O
    Halldin, C
    Dollé, F
    Swahn, CG
    Olsson, H
    Karlsson, P
    Hall, H
    Sandell, J
    Lundkvist, C
    Vaufrey, F
    Loc'h, C
    Crouzel, C
    Mazière, B
    Farde, L
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (05) : 509 - 518
  • [23] A PET-examination of [11C]DADAM in human brain -: A PET radioligand for the serotonin transporter with a fast equilibrium.
    Halldin, C
    Lundberg, J
    Tarkiainen, J
    Hiltunen, J
    Sovago, J
    Gulyas, B
    Guilloteau, D
    Emond, P
    Chalon, S
    Vercouillie, J
    Farde, L
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 68P - 68P
  • [24] Highly efficient synthesis of [11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET
    Dolle, F
    Bottlaender, M
    Demphel, S
    Emond, P
    Fuseau, C
    Coulon, C
    Ottaviani, M
    Valette, H
    Loc'h, C
    Halldin, C
    Mauclaire, L
    Guilloteau, D
    Maziere, B
    Crouzel, C
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (10): : 997 - 1004
  • [25] Highly efficient synthesis of [11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET
    Mazza, Samuel M.
    Journal of Labelled Compounds and Radiopharmaceuticals, 2000, 43 (10) : 997 - 1004
  • [26] [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
    Christer Halldin
    Nina Erixon-Lindroth
    Stefan Pauli
    Yuan-Hwa Chou
    Yoshiro Okubo
    Per Karlsson
    Camilla Lundkvist
    Hans Olsson
    Denis Guilloteau
    Patrick Emond
    Lars Farde
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1220 - 1230
  • [27] [11C]PE2I:: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
    Halldin, C
    Erixon-Lindroth, N
    Pauli, S
    Chou, YH
    Okubo, Y
    Karlsson, P
    Lundkvist, C
    Olsson, H
    Guilloteau, D
    Emond, P
    Farde, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) : 1220 - 1230
  • [28] PET examination of [11C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter
    Sandell, J
    Halldin, C
    Sovago, J
    Chou, YH
    Gulyás, B
    Yu, MX
    Emond, P
    Någren, K
    Guilloteau, D
    Farde, L
    NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (06) : 651 - 656
  • [29] Evaluation of [C-11]RTI-121 as a selective radioligand for PET studies of the dopamine transporter
    Hume, SP
    Luthra, SK
    Brown, DJ
    OpackaJuffry, J
    Osman, S
    Ashworth, S
    Myers, R
    Brady, F
    Carroll, FI
    Kuhar, MJ
    Brooks, DJ
    NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (03): : 377 - 384
  • [30] Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET.
    Lammertsma, AA
    Turjanski, N
    Hume, SP
    Luthra, SK
    Osman, S
    Piccini, P
    Brown, DJ
    Carroll, FI
    Brooks, DJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 426 - 426